Interleukin-1 amplifies the action of pituitary secretagogues via protein kinases.
Făgărăşan
M O
MO
Clinical Neuroscience Branch, National Institute of Mental Health and Peptide Design, Bethesda, Maryland 20892.
Axelrod
J
J
D000818:Animals; D002460:Cell Line; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D051379:Mice; D009638:Norepinephrine / Q000494:pharmacology; D010750:Phosphoproteins / Q000302:isolation & purification; D010766:Phosphorylation; D010903:Pituitary Gland, Anterior / Q000378:metabolism; D010911:Pituitary Neoplasms; D011493:Protein Kinase C / Q000378:metabolism; D011494:Protein Kinases / Q000378:metabolism*; D011994:Recombinant Proteins / Q000494:pharmacology*; D001615:beta-Endorphin / Q000378:metabolism*
D007375:Interleukin-1; D010750:Phosphoproteins; D011994:Recombinant Proteins; D001615:beta-Endorphin; D003346:Corticotropin-Releasing Hormone; D011494:Protein Kinases; D011493:Protein Kinase C; D007545:Isoproterenol; D009638:Norepinephrine